|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Section of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Correspondence to: Jorge A. Coss-Bu, MD, Critical Care Section, Texas Childrens Hospital, 6621 Fannin St, Suite 440, MC 2-3450, Houston, TX 77030-2399; e-mail: jorgec{at}bcm.tmc.edu
| Abstract |
|---|
|
|
|---|
E) and inefficient gas exchange due to a high level of physiologic dead space ventilation (VD/VT). Mechanical ventilation with positive end-expiratory pressure, when used in critically ill patients to correct hypoxemia, may contribute to increased VD/VT. The purpose of this study was to measure metabolic parameters and VD/VT in critically ill children. Design: A cross-sectional study.
Setting: Pediatric ICU of a university hospital.
Patients: A total of 45 mechanically intubated children (mean age, 5.5 years).
Interventions: Indirect calorimetry was used to measure metabolic parameters. VD/VT parameters were calculated using the modified Bohr-Enghoff equation. ARDS was defined based on criteria by The American-European Consensus Conference.
Measurements and results: The group mean (± SD) ventilatory equivalent for oxygen (VeqO2) and ventilatory equivalent for carbon dioxide (VeqCO2) were 2.9 ± 1 and 3.3 ± 1 L per 100 mL, respectively. The group mean VD/VT was 0.48 ± 0.2. When compared to non-ARDS patients (33 patients), the patients with ARDS (12 patients) had a significantly higher VeqO2 (3.3 ± 1 vs 2.8 ± 1 L per 100 mL, respectively; p < 0.05), a significantly higher VeqCO2 (3.7 ± 1 L/100 vs 3.1 ± 1 L per 100 mL, respectively; p < 0.05), and a significantly higher VD/VT (0.62 ± 0.14 vs 0.43 ± 0.15, respectively; p < 0.0005).
Conclusions: Critically ill children with ARDS have increased VD/VT. Increased VD/VT was the main cause of the excess of
E demand in these patients. Increased metabolic demands, as shown by the VeqO2, VeqCO2, and ventilatory support, are the major determinants of
E requirements in children with ARDS.
Key Words: acute lung injury critical care indirect calorimetry mechanical ventilation pediatrics respiratory dead space
| Introduction |
|---|
|
|
|---|
E) also has been reported in critically ill patients who are receiving mechanical ventilation,6
with this demand of
E being determined by the following three factors: carbon dioxide output (
CO2); PaCO2; and the efficiency of CO2 removal.7
Any increase in dead space will cause a decrease in the efficiency of CO2 removal and a consequent increase in the
E requirements out of proportion to the level of metabolic demand for gas exchange. The use of mechanical ventilation contributes to this increased physiologic dead space ventilation (VD/VT),8
9
10
11
12
as does inefficient gas exchange due to alterations in the distribution of the ventilation-perfusion relationship and a high level of VD/VT.13
14
15
16
17
Increased dead space has been reported14
15
18
19
20
21
in patients early on in the clinical course of ARDS and is thought to be associated with the presence of primary lung injury.
Studies in critically ill and mechanically ventilated adults have reported simultaneous measurements of metabolic parameters and VD/VT.6 22 23 Dead space measurements with simultaneous measurements of metabolic parameters also have been reported in critically ill and mechanically ventilated neonates,24 25 26 anesthetized infants and children undergoing cardiac surgery,27 28 29 30 31 32 and critically ill children.33
The purpose of this study was to measure metabolic and VD/VT parameters in critically ill children receiving ventilatory support and to assess the effect of lung injury on VD/VT in this population.
| Materials and Methods |
|---|
|
|
|---|
While receiving mechanical ventilation, a previously validated mass spectrometer for children was used to measure metabolic parameters by using a breath-by-breath technique of indirect calorimetry.34 Indirect calorimetry is a bedside technique that allows the accurate measurement of energy expenditure (EE). It involves the analysis of expired gas for oxygen and carbon dioxide levels and for the measurement of expired volume. When indirect calorimetry measurements by a metabolic cart are combined with arterial blood gas analysis for carbon dioxide, the VD/VT can be determined individually.
Demographic data were collected including the following: age; sex; and day-of-study data for weight, pediatric risk of mortality (PRISM) score, therapeutic intervention scoring system (TISS) score, length of stay in the pediatric ICU, and length of mechanical ventilation. Time-of-study data obtained from the ventilator settings included the following: fraction of inspired oxygen (FIO2); PEEP; tidal volume (VT);
E; synchronized intermittent mandatory ventilation (SIMV); peak inspiratory pressure (PIP); and mean airway pressure (Paw). The oxygenation index (ie, Paw x FIO2 x 100/PO2 in the blood) and the ventilation index (ie, PCO2 in the blood x PIP x SIMV/100) were calculated.
The metabolic parameters included the following: oxygen consumption (
O2);
CO2; VeqO2 (
E/
O2), VeqCO2 (
E/
CO2); and mixed expired carbon dioxide (PeCO2). The clinical protocol for the measurements have been described previously.35
At the same time as the metabolic evaluation, an arterial blood sample was obtained for PaCO2, and the modified Bohr-Enghoff equation36
(ie, PaCO2 - PeCO2/PaCO2) was used to calculate VD/VT. Spearman correlation was utilized to analyze the relationship between mechanical ventilation and VD/VT. The
PCO2was calculated. In order to assess differences in the calculation of the VD/VT, we used the following three different methods: (1) VD/VT I = the Bohr-Enghof equation; (2) VD/VT II = (end-tidal carbon dioxide - PeCO2)/end-tidal carbon dioxide; and (3) VD/VT III = [1 - (
CO2)/PaCO2 x
E)]. The Bland-Altman analysis was used to estimate bias and variability between the methods.37
Utilizing the definition by Tulla et al,38
increased VD/VT was defined as a value of > 0.40.
To evaluate the participation of PaCO2, VD/VT, and
CO2 in the amount of ventilatory support expressed as
E, each of these factors was assumed to have a normal value while the other two had the real values obtained for each patient. Therefore, three different values of
E were obtained (ie,
E I,
E II, and
E III).
E was calculated using the following formula:
E = 0.863 x
CO2 calculated/[PaCO2 x (1 - VD/VT)], with each correspondent value being substituted into the previous equation.
E I was defined as a PaCO2 value of 40 mm Hg,
E II was defined as a VD/VT value of 0.40, and
E III was defined as a calculated value of
CO2, where
CO2 calculated is the normal
CO2 from EE based on values from Talbot,39
and where EE = 5.68 x
O2 + 1.59 x
CO2. The calculated values for
E I,
E II, and
E III then were compared against the measured values.
To analyze the effect of lung injury on VD/VT parameters, the patients were divided in two groups (ARDS and non-ARDS) based on the criteria of the American-European Consensus Conference on ARDS.40 The t test was used to compare data between groups. The Spearman correlation was calculated when appropriate. All values are given as the mean ± SD.
| Results |
|---|
|
|
|---|
The mean ventilator parameters were as follows: FIO2, 0.50 ± 0.10; PEEP, 6 ± 2 cm H2O; VT, 11 ± 4 mL/kg;
E, 5.1 ± 2.9 L/min; SIMV, 18 ± 8 breaths/min; PIP, 46 ± 15 cm H2O; and Paw, 11 ± 5 cm H2O. The mean oxygenation index was 7 ± 6, and the mean ventilation index was 48 ± 42.
The group average metabolic measurements values showed a
O2 of 10 ± 5 mL/kg/min, a
CO2 of 9 ± 4 mL/kg/min, a VeqO2 of 2.9 ± 1 L per 100 mL, a VeqCO2 of 3.3 ± 1 L per 100 mL, and a PeCO2 of 24 ± 6 mm Hg. The dead space measurements showed an average VD/VT of 0.48 ± 0.2. The relationship between VD/VT and ventilatory parameters showed a correlation value for SIMV of 0.53 (p < 0.0005), for PEEP of 0.43 (p < 0.005), for VT of -0.08 (p = 0.59), and for VE of -0.20 (p = 0.17). The mean PaCO2 was 51 ± 18 mm Hg, and the mean
PCO2 was 5 ± 10 mm Hg. The average values of
E I,
E II, and
E III were 5.7 ± 3, 4.3 ± 3, and 3.5 ± 3 L/min, respectively.
The average bias between VD/VT I and VD/VT II was 0.04 (p < 0.005, different from zero), with a variability of 0.09 (Fig 1 ). The average bias between VD/VT I and VD/VT III was -0.02 (p < 0.005, different from zero), with a variability of 0.04 (Fig 1) .
|
PCO2 (16 ± 12 vs 1 ± 6 mm Hg, respectively; p < 0.0001) compared to patients without the criteria for ARDS. All the methods of calculating
E demonstrated a significant difference between patients with and without ARDS, for
E I (52 ± 55% vs 9 ± 26%, respectively; p < 0.005), for
E II (40 ± 22% vs 8 ± 24%, respectively; p < 0.0005), and for
E III (7 ± 29% vs 35 ± 22%, respectively; p < 0.005).
|
|
| Discussion |
|---|
|
|
|---|
Several studies6 10 13 have reported VD/VT results in mechanically ventilated preoperative adult patients, with values ranging from 0.31 to 0.36. The values reported in pediatric preoperative patients have ranged from 0.35 to 0.38.27 29 30 It has been described that patients with ARDS, sepsis, and trauma require increased ventilatory support to meet the higher ventilatory needs associated with a hypermetabolic state. This increased need for ventilatory support is associated with a concomitant change in VD/VT. A recent study by Nuckton et al41 found that increased dead space fraction as a consequence of pulmonary vascular injury42 43 was observed in adults patients with ARDS and was associated with an increased risk of death.
Several clinical studies6 13 16 41 have measured VD/VT in critically ill adult patients with ARDS with VD/VT values ranging from 0.46 to 0.69. The studies24 25 26 performed in newborn patients reported VD/VT values ranging from 0.47 to 0.62. A report by Lum et al33 measured VD/VT parameters in 12 critically ill children who were receiving mechanical ventilation (mean age, 5.6 years), and the mean VD/VT value was 0.38. The present study of 45 critically ill children who were receiving mechanical ventilation showed a mean VD/VT value of 0.48. This result was not significantly different when compared to the values reported in the above-mentioned studies that were conducted in newborn and adult patients (Table 2 ).
|
In a prospective study by Nuckton et al,41 the authors measured the dead space fraction in 179 adult patients who were receiving ventilatory support and had a diagnosis of ARDS, and the results showed a significantly higher mean dead space fraction among the patients who died compared to the survivors (0.63 vs 0.54, respectively). These values are similar to the results seen in our study. The findings of the study by Nuckton et al,41 indicate that a substantial increase in alveolar dead space occurs very early in the course of the ARDS, reflecting the extent of pulmonary vascular injury.
The relationship of ventilatory support and VD/VT in the present study showed a significant correlation of SIMV, PEEP, and Paw with VD/VT, without a significant correlation with VT or
E. The mechanisms that explain the changes in dead space, in relation to respiratory frequency, are based on the observation that a slower frequency allows for more even ventilation and for emptying of all alveolar units, particularly units with a prolonged time constant. This is similar to the described higher VD/VT per minute in infants, as related to a faster resting respiratory frequency.30
The use of PEEP as a method to increase Paw in critically ill patients is a common intervention that is used to improve oxygenation and to restore a low functional residual capacity. With the use of higher distending pressures, some lung areas will be overdistended, resulting in fewer alveolar units participating in gas exchange and an increase in dead space. In this study, we did not find a significant relationship between VD/VT and VT, but a significant correlation was noted between physiologic dead space (volume) and VT. Several studies have reported a significant correlation between physiologic dead space and VT in anesthetized dogs,45 in anesthetized patients,46 and in critically ill patients with ARDS.17 The increase in VT will result in a proportional increase in alveolar ventilation, but this change in alveolar ventilation is attenuated by a concomitant change in physiologic dead space.
The use of different formulas to calculate dead space has been described in the literature. The initial description of calculating the dead space based on the measurement of exhaled gas was published in 1891 by Bohr.47
In 1938, Enghoff48
modified the original equation by substituting the value of PACO2 by the use of PaCO2. Several studies using the original Bohr equation have reported VD/VT results in preoperative patients.10
23
30
Some reports have documented the significance of using the modified Bohr-Enghoff equation in order to accurately calculate VD/VT parameters, particularly in patients with lung disease16
and pulmonary hypoperfusion.27
29
In these patients, the difference between PACO2 and PaCO2 increases with decreasing pulmonary blood flow and a increased amount of intrapulmonary shunting. In our study, the
PCO2 was significantly higher in patients with ARDS, with an average value of 16 mm Hg, compared to an average value of 1 mm Hg in patients without the criteria for ARDS. The result of using PACO2 values in the patients having either lung disease or decreased pulmonary flow will result in an underestimation of physiologic dead space and an overestimation of alveolar dead space.
The present study reports the results of comparing three different formulas used to calculate VD/VT by using the Bland-Altman analysis. The results showed significant bias and large variability when comparing the Bohr-Enghoff equation against the other two formulas. In critically ill pediatric patients, it appears that the use of PACO2 will carry a significant error in the calculation of VD/VT.
The use of the VeqO2 has been described22
as a parameter with which to assess the ability of the lung to extract oxygen. A large value suggests that the patient is unable to support metabolic demands without ventilatory assistance.22
In this study, the VeqO2 in ARDS patients was significantly higher compared to that in non-ARDS patients, implying that an elevated
E is needed to compensate for the inability of the injured lung to extract oxygen and deliver it to the tissues. The VeqCO2 is the ventilatory indication of the degree of inefficiency in the pulmonary removal of carbon dioxide. Patients with ARDS had a significantly higher value compared to non-ARDS patients as a consequence of the lung becoming less efficient in removing carbon dioxide.
It is known that the level of carbon dioxide and increased VD/VT are important factors in the ventilatory needs of critically ill patients. The level of carbon dioxide and the VD/VT had major impacts on
E needs in patients with ARDS, accounting for changes of 52% and 40%, respectively, in the measured
E, assuming normal values for each of these two parameters. The influence of carbon dioxide production was not significant in the amount needed for
E, probably because the patients with ARDS had a lower measured value, reducing the participation of this parameter in the calculation of
E.
In summary, in critically ill children the major determinants of
E and VD/VT are significant lung injury and increased metabolic demands. The use of PaCO2 is important in the accurate calculation of dead space in patients with significant lung injury.
| Footnotes |
|---|
CO2 = carbon dioxide output; VD/VT = physiologic dead space ventilation;
E = minute ventilation; VeqCO2 = ventilatory equivalent for carbon dioxide; VeqO2 = ventilatory equivalent for oxygen;
O2 = oxygen consumption; VT = tidal volume This research was supported by the National Institutes of Health General Clinical Research Center and by the Genevieve R. McClelland Fund for Pediatric Intensive Care Research.
Received for publication March 21, 2002. Accepted for publication October 29, 2002.
| References |
|---|
|
|
|---|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |